In terms of pathophysiology, the over-activation of the NLRP3 inflammasome in vascular cells has been tightly associated with vascular diseases, such as atherosclerosis, stroke or hypertension, and, more recently, with COVID-19-associated vasculopathy and hyperinflammation [40, 41]. This evidence concerns the gene NLRP3 and atherosclerosis.